[1]
|
Litwin, M., Grenda, R., Prokurat, S., Abuauba, M., Latoszynska, J., Jobs, K., Boguszewska-Baczkowska, A. and Wawer, Z.T. (2001) Patient Survival and Causes of Death on Hemodialysis and Peritoneal Dialysis-Single-Center Study. Pediatric Nephrology, 16, 996-1001. https://doi.org/10.1007/s004670100012
|
[2]
|
Groothoff, J.W., Gruppen, M.P., Offringa, M., Hutten, J., Lilien, M.R., Van De Kar, N.J., Wolff, E.D., Davin, J.C. and Heymans, H.S. (2002) Mortality and Causes of Death of End-Stage Renal Disease in Children: A Dutch Cohort Study. Kidney International, 61, 621-629. https://doi.org/10.1046/j.1523-1755.2002.00156.x
|
[3]
|
Rinat, C., Becker-Cohen, R., Nir, A., Feinstein, S., Shemesh, D., Algur, N., Ben Shalom, E., Farber, B. and Frishberg, Y. (2010) A Comprehensive Study of Cardiovascular Risk Factors, Cardiac Function and Vascular Disease in Children with Chronic Renal Failure. Nephrology Dialysis Transplantation, 25, 785-793. https://doi.org/10.1093/ndt/gfp570
|
[4]
|
Parekh, R.S., Carroll, C.E., Wolfe, R.A. and Port, F.K. (2002) Cardiovascular Mortality in Children and Young Adults with End-Stage Kidney Disease. The Journal of Pediatrics, 141, 191-197. https://doi.org/10.1067/mpd.2002.125910
|
[5]
|
Chavers, B.M., Molony, J.T., Solid, C.A., Rheault, M.N. and Collins, A.J. (2015) One-Year Mortality Rates in US Children with End-Stage Renal Disease. American Journal of Nephrology, 41, 121-128. https://doi.org/10.1159/000380828
|
[6]
|
Kari, J.A., Donald, A.E., Vallance, D.T., Bruckdorfer, K.R., Leone, A., Mullen, M.J., Bunce, T., Dorado, B., Deanfield, J.E. and Rees, L. (1997) Physiology and Biochemistry of Endothelial Function in Children with Chronic Renal Failure. Kidney International, 52, 468-472. https://doi.org/10.1038/ki.1997.354
|
[7]
|
Shroff, R.C., Donald, A.E., Hiorns, M.P., Watson, A., Feather, S., Milford, D., Ellins, E.A., Storry, C., Ridout, D., Dean-field, J. and Rees, L. (2007) Mineral Metabolism and Vascular Damage in Children on Dialysis. Journal of the American Society of Nephrology, 18, 2996-3003. https://doi.org/10.1681/ASN.2006121397
|
[8]
|
Hothi, D.K., Harvey, E., Goia, C.M. and Geary, D. (2008) Blood-Volume Monitoring in Paediatric Haemodialysis. Pediatric Nephrology, 23, 813-820. https://doi.org/10.1007/s00467-007-0724-7
|
[9]
|
Prkacin, I., Jurekovic, Z., Perkov, S., Savuk, A., Pikivaca, T., Golub, A. and Svagusa, T. (2018) High Sensitive Troponin Concentration Stability in Dialysate of Anuric Patients on Hemodialysis. Signa Vitae: Journal for Intensive Care and Emergency Medicine, 14, 35-38.
|
[10]
|
Yildiz, G., Kayatas, M., Candan, F., Yilmaz, M.B., Zorlu, A. and Sarikaya, S. (2013) What Is the Meaning of Increased Myocardial Injury Enzymes during Hemodialysis? A Tissue Doppler Imaging Study. Cardiorenal Medicine, 3, 136-153. https://doi.org/10.1159/000353154
|
[11]
|
Ingec, M., Oguz, E.G., Yildirim, T., Ulas, T. and Horoz, M. (2014) The Effect of Hemodialysis on Cardiac Enzyme Levels and Echocardiographic Parameters. The International Journal of Artificial Organs, 37, 513-520. https://doi.org/10.5301/ijao.5000333
|
[12]
|
Kumar, N., Michelis, M.F., DeVita, M.V., Panagopoulos, G. and Rosenstock, J.L. (2011) Troponin I Levels in Asymptomatic Patients on Haemodialysis Using a High-Sensitivity Assay. Nephrology Dialysis Transplantation, 26, 665-670. https://doi.org/10.1093/ndt/gfq442
|
[13]
|
Cardinaels, E.P., Cornelis, T., van der Sande, F.M., Leunissen, K.M., van Dieijen-Visser, M.P., Mingels, A.M., Kooman, J.P. and Bekers, O. (2015) Acute Effects of Conventional and Extended Hemodialysis and Hemodiafiltration on High-Sensitivity Cardiac Troponins. Clinical Chemistry and Laboratory Medicine (CCLM), 53, e289-e292. https://doi.org/10.1515/cclm-2015-0201
|
[14]
|
Pervan, P., Svagusa, T., Perkov, S. and Prkacin, I. (2017) Troponina I u urinu. Acta Medica Croatica. (In Press)
|
[15]
|
Locatelli, F., Nissenson, A.R., Barrett, B.J., Walker, R.G., Wheeler, D.C., Eckardt, K.U., Lameire, N.H. and Eknoyan, G. (2008) Clinical Practice Guidelines for Anemia in Chronic Kidney Disease: Problems and Solutions. A Position Statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International, 74, 1237-1240. https://doi.org/10.1038/ki.2008.299
|
[16]
|
Zoltani, C.K. (2014) Cardiovascular Toxicity Biomarkers. In: Biomarkers in Toxicology, Elsevier, Amsterdam, 199-215. https://doi.org/10.1016/B978-0-12-404630-6.00011-7
|
[17]
|
Thygesen, K., Alpert, J.S., White, H.D. and Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction (2007) Universal Definition of Myocardial Infarction. Journal of the American College of Cardiology, 50, 2173-2195. https://doi.org/10.1016/j.jacc.2007.09.011
|
[18]
|
Beciani, M., Tedesco, A., Violante, A., Cipriani, S., Azzarito, M., Sturniolo, A. and Splendiani, G. (2003) Cardiac Troponin I (2nd Generation Assay) in Chronic Haemodialysis Patients: Prevalence and Prognostic Value. Nephrology Dialysis Transplantation, 18, 942-946. https://doi.org/10.1093/ndt/gfg057
|
[19]
|
Hirsch, R., Landt, Y., Porter, S., Canter, C.E., Jaffe, A.S., Ladenson, J.H., Grant, J.W. and Landt, M. (1997) Cardiac Troponin I in Pediatrics: Normal Values and Potential Use in the Assessment of Cardiac Injury. The Journal of Pediatrics, 130, 872-877. https://doi.org/10.1016/S0022-3476(97)70271-3
|
[20]
|
Gaiki, M.R., DeVita, M.V., Michelis, M.F., Panagopoulos, G. and Rosenstock, J.L. (2012) Troponin I as a Prognostic Marker of Cardiac Events in Asymptomatic Hemodialysis Patients Using a Sensitive Troponin I Assay. International Urology and Nephrology, 44, 1841-1845. https://doi.org/10.1007/s11255-012-0128-x
|
[21]
|
Artunc, F., Mueller, C., Breidthardt, T., Twerenbold, R., Peter, A., Thamer, C., Weyrich, P., Haering, H.U. and Friedrich, B. (2012) Sensitive Troponins—Which Suits Better for Hemodialysis Patients? Associated Factors and Prediction of Mortality. https://doi.org/10.1371/journal.pone.0047610
|
[22]
|
Assa, S., Gansevoort, R.T., Westerhuis, R., Kobold, A.C.M., Voors, A.A., de Jong, P.E., Bakker, S.J. and Franssen, C.F. (2013) Determinants and Prognostic Significance of an Intra-Dialysis Rise of Cardiac Troponin I Measured by Sensitive Assay in Hemodialysis Patients. Clinical Research in Cardiology, 102, 439-445. https://doi.org/10.1007/s00392-013-0551-8
|
[23]
|
Skadberg, Ø., Sandberg, S., RØraas, T., Petersen, P.H., Sellevoll, H., Svarstad, E., Sæle, K. and Aakre, K.M. (2016) The Variation in High Sensitive Cardiac Troponin Concentration during Haemodialysis Treatment Is Not Similar to the Biological Variation Observed in Stable end Stage Renal Disease Patients. Scandinavian Journal of Clinical and Laboratory Investigation, 76, 645-652. https://doi.org/10.1080/00365513.2016.1230886
|
[24]
|
Tarapan, T., Musikatavorn, K., Phairatwet, P., Takkavatakarn, K., Susantitaphong, P., Eiam-Ong, S. and Tiranathanagul, K. (2019) High Sensitivity Troponin-I Levels in Asymptomatic Hemodialysis Patients. Renal Failure, 41, 393-400. https://doi.org/10.1080/0886022X.2019.1603110
|
[25]
|
Antlanger, M., Hecking, M., Haidinger, M., Werzowa, J., Kovarik, J.J., Paul, G., Eigner, M., Bonderman, D., Hörl, W.H. and Säemann, M.D. (2013) Fluid Overload in Hemodialysis Patients: A Cross-Sectional Study to Determine Its Association with Cardiac Biomarkers and Nutritional Status. BMC Nephrology, 14, 266. https://doi.org/10.1186/1471-2369-14-266
|
[26]
|
Breidthardt, T., Burton, J.O., Odudu, A., Eldehni, M.T., Jefferies, H.J. and McIntyre, C.W. (2012) Troponin T for the Detection of Dialysis-Induced Myocardial Stunning in Hemodialysis Patients. Clinical Journal of the American Society of Nephrology, 7, 1285-1292. https://doi.org/10.2215/CJN.00460112
|
[27]
|
Diris, J.H., Hackeng, C.M., Kooman, J.P., Pinto, Y.M., Hermens, W.T. and van Dieijen-Visser, M.P. (2004) Impaired Renal Clearance Explains Elevated Troponin T Fragments in Hemodialysis Patients. Circulation, 109, 23-25. https://doi.org/10.1161/01.CIR.0000109483.45211.8F
|
[28]
|
Fahim, M.A., Hayen, A.D., Horvath, A.R., Dimeski, G., Coburn, A., Tan, K.S., Johnson, D.W., Craig, J.C., Campbell, S.B. and Hawley, C.M. (2015) Biological Variation of High Sensitivity Cardiac Troponin-T in Stable Dialysis Patients: Implications for Clinical Practice. Clinical Chemistry and Laboratory Medicine (CCLM), 53, 715-722. https://doi.org/10.1515/cclm-2014-0838
|
[29]
|
Buiten, M.S., de Bie, M.K., Rotmans, J.I., Dekker, F.W., van Buren, M., Rabelink, T.J., Cobbaert, C.M., Schalij, M.J., van der Laarse, A. and Jukema, J.W. (2015) Serum Cardiac Troponin-I Is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease. PLoS ONE, 10, e0134245. https://doi.org/10.1371/journal.pone.0134245
|
[30]
|
Wildi, K., Twerenbold, R. and Mueller, C. (2015) How Acute Changes in Cardiac Troponin Concentrations Help to Handle the Challenges Posed by Troponin Elevations in Non-ACS-Patients. Clinical Biochemistry, 48, 218-222. https://doi.org/10.1016/j.clinbiochem.2014.09.003
|
[31]
|
Agewall, S. and Tjora, S. (2011) Physical Exertion May Cause High Troponin Levels. Tidsskr Nor Lae-geforen, 131, 2226. https://doi.org/10.4045/tidsskr.11.0815
|
[32]
|
Burton, J.O., Jefferies, H.J., Selby, N.M. and McIntyre, C.W. (2009) Hemodialysis-Induced Cardiac Injury: Determinants and Associated Outcomes. Clinical Journal of the American Society of Nephrology, 4, 914-920. https://doi.org/10.2215/CJN.03900808
|
[33]
|
Hung, S.Y., Hung, Y.M., Fang, H.C., Yeh, J.H., Hung, G.C., Wu, C.J., Chou, K.J. and Chung, H.M. (2004) Cardiac Troponin I and Creatine Kinase Isoenzyme MB in Patients with Intradialytic Hypotension. Blood Purification, 22, 338-343. https://doi.org/10.1159/000079188
|
[34]
|
Thygesen, K., Alpert, J.S. and White, H.D. (2007) Universal Definition of Myocardial Infarction. European Heart Journal, 28, 2525-2538.
|
[35]
|
Hessel, M.H., Michielsen, E.C., Atsma, D.E., Schalij, M.J., van der Valk, E.J., Bax, W.H., et al. (2008) Release Kinetics of Intact and Degraded Troponin I and T after Irreversible Cell Damage. Experimental and Molecular Pathology, 85, 90-95. https://doi.org/10.1016/j.yexmp.2008.07.002
|
[36]
|
Kaplan, S. (1997) Biochemical Markers of Myocardial Injury in Children. Circulation, 96, 2496-2497.
|
[37]
|
Noori, N.M., Keshavarz, K. and Shahriar, M. (2012) Cardiac and Pulmonary Dysfunction in Asymptomatic Beta-Thalassanemia Major. Asian Cardiovascular and Thoracic Annals, 20, 555-559. https://doi.org/10.1177/0218492312439706
|
[38]
|
Adams Jr., K.F., Mehra, M.R., Oren, R.M., O’Connor, C.M., Chiong, J.R., Ghali, J.K., et al. (2010) Prospective Evaluation of the Association between Cardiac Troponin T and Markers of Disturbed Erythropoiesis in Patients with Heart Failure. American Heart Journal, 160, 1142-1148. https://doi.org/10.1016/j.ahj.2010.07.033
|
[39]
|
Tun, A., Khan, I.A., Win, M.T., Hussain, A., Hla, T.A., Wattanasuwan, N., et al. (1998) Specificity of Cardiac Troponin I and Creatine Kinase-MB Isoenzyme in Asymptomatic Long-Term Hemodialysis Patients and Effect of Hemodialysis on These Cardiac Markers. Cardiology, 90, 280-285. https://doi.org/10.1159/000006859
|
[40]
|
Farkouh, M.E., Robbins, M.J., Zafar, M.U., Shimbo, D., Davidson, K.W., Puttappa, R., et al. (2003) Association between Troponin I Levels and Mortality in Stable Hemodialysis Patients. The American Journal of Medicine, 114, 224-226. https://doi.org/10.1016/S0002-9343(02)01482-1
|
[41]
|
Deleaval, P., Descombes, E., Magnin, J.L., Martin, P.Y. and Fellay, G. (2006) Differences in Cardiac Troponin I and T Levels Measured in Asymptomatic Hemodialysis Patients with Last Generation Immunoassays. Néphrologie & Thérapeutique, 2, 75-81.
|
[42]
|
Wayand, D., Baum, H., Schatzle, G., Scharf, J. and Neumeier, D. (2000) Cardiac Troponin T and I in End-Stage Renal Failure. Clinical Chemistry, 46, 1345-1350. https://doi.org/10.1093/clinchem/46.9.1345
|
[43]
|
Lippi, G., Tessitore, N., Montagnana, M., Salvagno, G.L., Lupo, A. and Guidi, G.C. (2008) Influence of Sampling Time and Ultrafiltration Coefficient of the Dialysis Membrane on Cardiac Troponin I and T. Archives of Pathology & Laboratory Medicine, 132, 72-76. https://doi.org/10.5858/2008-132-72-IOSTAU
|
[44]
|
Fouque, D., Kalantar-Zadeh, K., Kopple, J., Cano, N., Chauveau, P., Cuppari, L., Franch, H., et al. (2008) A Proposed Nomenclature and Diagnostic Criteria for Protein-Energy Wasting in Acute and Chronic Kidney Disease. Kidney International, 73, 391-398. https://doi.org/10.1038/sj.ki.5002585
|
[45]
|
Sur, M.M. and México, D.F. (2010) Body Fluid Volume and Nutritional Status in Hemodialysis: Vector Bioelectric Impedance Analysis. Clinical Nephrology, 73, 300-308.
|
[46]
|
Degoma, E.M., Leeper, N.J. and Heidenreich, P.A. (2008) Clinical Significance of High-Density Lipoprotein Cholesterol in Patients with Low Low-Density Lipoprotein Cholesterol. Journal of the American College of Cardiology, 51, 49-55. https://doi.org/10.1016/j.jacc.2007.07.086
|
[47]
|
Nayak, S.B., Pinto Pereira, L.M., Boodoo, S., KimberlyAli, A., Baptiste, C., Maraj, S., Persad, N., Khan, N., Surendran, S. and Legall, G. (2010) Association of Troponin T and Altered Lipid Profile in Patients Admitted with Acute Myocardial Infarction. Archives of Physiology and Biochemistry, 116, 21-27. https://doi.org/10.3109/13813450903397638
|
[48]
|
Patanè, S., Marte, F., Di Bella, G., Currò, A. and Coglitore, S. (2008) QT Interval Prolongation, Torsade de Pointes and Renal Disease. International Journal of Cardiology, 130, e71-e73. https://doi.org/10.1016/j.ijcard.2007.11.070
|
[49]
|
Familoni, O.B., Alebiosu, C.O. and Ayodele, O.E. (2006) Effects and Outcome of Haemodialysis on QT Intervals and QT Dispersion in Patients with Chronic Kidney Disease: Cardiovascular Topics. Cardiovascular Journal of South Africa, 17, 19-23.
|
[50]
|
Sherif, K.A., Abo-Salem, E., Panikkath, R., Nusrat, M. and Tuncel, M. (2014) Cardiac Repolarization Abnormalities among Patients with Various Stages of Chronic Kidney Disease. Clinical Cardiology, 37, 417-421. https://doi.org/10.1002/clc.22277
|
[51]
|
Näppi, S.E., Virtanen, V.K., Saha, H.H., Mustonen, J.T. and Pasternack, A.I. (2000) QTc Dispersion Increases during Hemodialysis with Low-Calcium Dialysate. Kidney International, 57, 2117-2122. https://doi.org/10.1046/j.1523-1755.2000.00062.x
|
[52]
|
Niaki, M.R.K., Saravi, M., Oliaee, F., Akbari, R., Noorkhomami, S., Rad, S.H.B., Fallahpoor, K. and Ramezani, M.S. (2013) Changes in QT Interval before and after Hemodialysis. Caspian Journal of Internal Medicine, 4, 590.
|
[53]
|
Oktavia, D., Nasution, S.A. and Setiati, S. (2013) The Clinical Factors’ Prediction of Increased Intradialytic qt Dispersion on the Electrocardiograms of Chronic Hemodialysis Patients. Saudi Journal of Kidney Diseases and Transplantation, 24, 274. https://doi.org/10.4103/1319-2442.109571
|
[54]
|
Genovesi, S., Rossi, E., Nava, M., Riva, H., De Franceschi, S., Fabbrini, P., et al. (2013) A Case Series of Chronic Haemodialysis Patients: Mortality, Sudden Death, and QT Interval. Europace, 15, 1025-1033. https://doi.org/10.1093/europace/eus412
|
[55]
|
Liu, P., Han, D., Sun, X., Tan, H., Wang, Z., Liu, C., et al. (2019) Prevalence and Risk Factors of Acquired Long QT Syndrome in Hospitalized Patients with Chronic Kidney Disease. Journal of Investigative Medicine, 67, 289-294. https://doi.org/10.1136/jim-2018-000798
|
[56]
|
Littmann, L. (1999) Large T Wave Inversion and QT Prolongation Associated with Pulmonary Edema: A Report of Nine Cases. Journal of the American College of Cardiology, 34, 1106-1110. https://doi.org/10.1016/S0735-1097(99)00311-3
|
[57]
|
Ozdemir, D., Mese, T., Agin, H., Calkavur, S. and Bak, M. (2005) Impact of Haemodialysis on QTc Dispersion in Children. Nephrology, 10, 119-123. https://doi.org/10.1111/j.1440-1797.2005.00378.x
|
[58]
|
Valsangiacomo, E., Neuhaus, T.J., Goetschel, P. and Bauersfeld, U. (2002) Cardiac Rhythm Disturbances in Children on Hemodialysis. Pediatric Nephrology, 17, 837-841. https://doi.org/10.1007/s00467-002-0976-1
|
[59]
|
Adiele, D.K., Okafor, H.U., Ojinnaka, N.C., Onwubere, B.J., Odetunde, O.I. and Uwaezuoke, S.N. (2014) Echocardiographic Findings in Children with Chronic Kidney Disease as Seen in the Resource-Limited Setting. Néphrologie & Thérapeutique, 4, 2161-0959. https://doi.org/10.4172/2161-0959.1000158
|
[60]
|
Beaubien, E.R., Pylypchuk, G.B., Akhtar, J. and Biem, H.J. (2002) Value of Corrected QT Interval Dispersion in Identifying Patients Initiating Dialysis at Increased Risk of Total and Cardiovascular Mortality. American Journal of Kidney Diseases, 39, 834-842. https://doi.org/10.1053/ajkd.2002.32005
|
[61]
|
Shahramian, I., Razzaghian, M., Ramazani, A.A., Ahmadi, G.A., Noori, N.M. and Rezaee, A.R. (2013) The Correlation between Troponin and Ferritin Serum Levels in the Patients with Major Beta-Thalassemia. International Cardiovascular Research Journal, 7, 51.
|
[62]
|
Wood, J.C. (2011) Impact of Iron Assessment by MRI. Hematology, No. 1, 443-450. https://doi.org/10.1182/asheducation-2011.1.443
|
[63]
|
van Ballegooijen, A.J., Visser, M., Kestenbaum, B., Siscovick, D.S., de Boer, I.H., Gottdiener, J.S., et al. (2013) Relation of Vitamin D and Parathyroid Hormone to Cardiac Biomarkers and to Left Ventricular Mass (from the Cardiovascular Health Study). The American Journal of Cardiology, 111, 418-424. https://doi.org/10.1016/j.amjcard.2012.10.021
|
[64]
|
Tastan, I., Schreckenberg, R., Mufti, S., Abdallah, Y., Piper, H.M. and Schlüter, K.D. (2009) Parathyroid Hormone Improves Contractile Performance of Adult Rat Ventricular Cardiomyocytes at Low Concentrations in a Non-Acute Way. Cardiovascular Research, 82, 77-83. https://doi.org/10.1093/cvr/cvp027
|
[65]
|
Kestenbaum, B., Katz, R., de Boer, I., Hoofnagle, A., Sarnak, M.J. and Shlipak, M.G. (2011) Vitamin D, Parathyroid Hormone, and Cardiovascular Events among Older Adults. Journal of the American College of Cardiology, 58, 1433-1441. https://doi.org/10.1016/j.jacc.2011.03.069
|
[66]
|
Saleh, F.N., Schirmer, H., Sundsfjord, J. and Jorde, R. (2003) Parathyroid Hormone and Left Ventricular Hypertrophy. European Heart Journal, 24, 2054-2060. https://doi.org/10.1016/j.ehj.2003.09.010
|
[67]
|
Hagström, E., Ingelsson, E., Sundström, J., Hellman, P., Larsson, T.E., Berglund, L., et al. (2010) Plasma Parathyroid Hormone and Risk of Congestive Heart Failure in the Community. European Journal of Heart Failure, 12, 1186-1192. https://doi.org/10.1093/eurjhf/hfq134
|
[68]
|
Matsuo, T. and Wanaka, K. (2011) Heparin-Induced Thrombocytopenia and Hemodialysis. Journal of Blood Disorders and Transfusion, 2, 002. https://doi.org/10.4172/2155-9864.S2-002
|
[69]
|
Daugirdas, J.T. and Bernardo, A.A. (2012) Hemodialysis Effect on Platelet Count and Function and Hemodialysis-Associated Thrombocytopenia. Kidney International, 82, 147-157. https://doi.org/10.1038/ki.2012.130
|
[70]
|
Davì, G. and Patrono, C. (2007) Platelet Activation and Atherothrombosis. New England Journal of Medicine, 357, 2482-2494. https://doi.org/10.1056/NEJMra071014
|
[71]
|
Coppinger, J.A., Cagney, G., Toomey, S., Kislinger, T., Belton, O., McRedmond, J.P., et al. (2004) Characterization of the Proteins Released from Activated Platelets Leads to Localization of Novel Platelet Proteins in Human Atherosclerotic Lesions. Blood, 103, 2096-2104. https://doi.org/10.1182/blood-2003-08-2804
|